The study will enroll 200 women newly diagnosed with peripartum cardiomyopathy within 5 months postpartum in a randomized placebo controlled trial of bromocriptine therapy to evaluate its impact on myocardial recovery and clinical outcomes. Given…
- Investigator
- Alex M Parker
- Ages
- 18 Years - N/A
- Sexes
- Female